Natixis Advisors, L.P. Novo Nordisk A S Transaction History

Natixis Advisors, L.P.

$51.3 Billion
Q3 2024

A detailed history of Natixis Advisors, L.P. transactions in Novo Nordisk A S stock. As of the latest transaction made, Natixis Advisors, L.P. holds 3,074,876 shares of NVO stock, worth $324 Million. This represents 0.71% of its overall portfolio holdings.

Number of Shares

3,074,876

Previous 2,994,806 2.67%

Holding current value

$324 Million

Previous $427 Million 14.35%

% of portfolio

0.71%

Previous 0.93%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	BUY	$119.07 - $145.42 $9.53 Million - $11.6 Million	80,070 Added 2.67%	3,074,876 $366 Million
Q2 2024 Aug 01, 2024	BUY	$122.71 - $146.91 $103,812 - $124,285	846 Added 0.03%	2,994,806 $427 Million
Q1 2024 Apr 25, 2024	SELL	$102.11 - $135.92 $5.97 Million - $7.94 Million	-58,446 Reduced 1.91%	2,993,960 $384 Million
Q4 2023 Feb 06, 2024	BUY	$87.78 - $105.45 $4.86 Million - $5.83 Million	55,333 Added 1.85%	3,052,406 $316 Million
Q3 2023 Nov 13, 2023	BUY	$90.94 - $199.54 $134 Million - $293 Million	1,469,489 Added 96.2%	2,997,073 $273 Million
Q2 2023 Aug 15, 2023	BUY	$155.98 - $172.65 $3.43 Million - $3.79 Million	21,980 Added 1.46%	1,527,584 $247 Million
Q1 2023 May 11, 2023	BUY	$132.34 - $159.14 $6.26 Million - $7.52 Million	47,277 Added 3.24%	1,505,604 $240 Million
Q4 2022 Jan 27, 2023	SELL	$102.55 - $135.33 $2.62 Million - $3.46 Million	-25,593 Reduced 1.72%	1,458,327 $197 Million
Q3 2022 Nov 14, 2022	BUY	$95.28 - $116.93 $7.19 Million - $8.83 Million	75,498 Added 5.36%	1,483,920 $148 Million
Q2 2022 Aug 12, 2022	BUY	$103.24 - $121.81 $20.9 Million - $24.7 Million	202,645 Added 16.81%	1,408,422 $157 Million
Q1 2022 May 12, 2022	BUY	$93.1 - $112.54 $17.8 Million - $21.5 Million	190,713 Added 18.79%	1,205,777 $134 Million
Q4 2021 Feb 08, 2022	SELL	$95.88 - $117.08 $26.3 Million - $32.2 Million	-274,788 Reduced 21.3%	1,015,064 $114 Million
Q3 2021 Nov 15, 2021	BUY	$84.42 - $106.62 $26.5 Million - $33.4 Million	313,585 Added 32.12%	1,289,852 $124 Million
Q2 2021 Aug 12, 2021	SELL	$67.66 - $84.76 $1.24 Million - $1.55 Million	-18,256 Reduced 1.84%	976,267 $81.8 Million
Q1 2021 May 05, 2021	BUY	$67.06 - $75.82 $4.38 Million - $4.95 Million	65,330 Added 7.03%	994,523 $67.1 Million
Q4 2020 Feb 12, 2021	SELL	$63.89 - $73.8 $7.69 Million - $8.88 Million	-120,346 Reduced 11.47%	929,193 $64.9 Million
Q3 2020 Nov 12, 2020	SELL	$63.69 - $70.22 $1.56 Million - $1.72 Million	-24,458 Reduced 2.28%	1,049,539 $72.9 Million
Q2 2020 Aug 11, 2020	SELL	$58.54 - $67.94 $25.7 Million - $29.9 Million	-439,625 Reduced 29.04%	1,073,997 $70.3 Million
Q1 2020 Apr 27, 2020	SELL	$49.46 - $64.78 $9.83 Million - $12.9 Million	-198,846 Reduced 11.61%	1,513,622 $91.1 Million
Q4 2019 Feb 10, 2020	SELL	$49.86 - $58.26 $3.38 Million - $3.94 Million	-67,704 Reduced 3.8%	1,712,468 $99.1 Million
Q3 2019 Nov 12, 2019	SELL	$47.54 - $53.43 $3.25 Million - $3.65 Million	-68,329 Reduced 3.7%	1,780,172 $92 Million
Q2 2019 Aug 12, 2019	BUY	$46.79 - $52.47 $256,736 - $287,902	5,487 Added 0.3%	1,848,501 $94.3 Million
Q1 2019 May 15, 2019	BUY	$46.36 - $52.63 $2.82 Million - $3.2 Million	60,802 Added 3.41%	1,843,014 $96.4 Million
Q4 2018 Feb 13, 2019	BUY	$41.54 - $47.25 $76,932 - $87,507	1,852 Added 0.1%	1,782,212 $82.1 Million
Q3 2018 Nov 13, 2018	BUY	$46.76 - $51.24 $11.7 Million - $12.8 Million	249,822 Added 16.32%	1,780,360 $83.9 Million
Q2 2018 Aug 14, 2018	SELL	$44.29 - $50.42 $9.2 Million - $10.5 Million	-207,820 Reduced 11.95%	1,530,538 $0
Q1 2018 May 10, 2018	SELL	$48.49 - $58.14 $1.21 Million - $1.46 Million	-25,054 Reduced 1.42%	1,738,358 $85.6 Million
Q4 2017 Feb 14, 2018	BUY	$47.53 - $53.73 $2.53 Million - $2.86 Million	53,188 Added 3.11%	1,763,412 $94.6 Million
Q3 2017 Nov 14, 2017	BUY	$41.15 - $49.22 $70.4 Million - $84.2 Million	1,710,224	1,710,224 $82.3 Million

Others Institutions Holding NVO

# of Institutions

1,952

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $238B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis Advisors, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Natixis Advisors, L.P. with notifications on news.

Account

Natixis Advisors, L.P. Novo Nordisk A S Transaction History